The protective efficacy of the enterotoxigenic Escherichia coli vaccine candidate by GI24 against neonatal piglet colibacillosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Enterotoxigenic Escherichia coli (ETEC) strains producing each F4, F5, F6 and F41 fimbriae were lysed by GI24 peptide. The lysate cells were used as ETEC vaccine candidate. This study was carried out to examine whether intramuscular (im) immunization of pregnant sows with the novel vaccine candidate could effectively protect their neonatal piglets against ETEC colibacillosis. All pregnant sows were primed at 11 weeks and were boosted at 14 weeks of pregnancy. Group A sows were im inoculated with PBS. Group B sows were im immunized with 2×109 the mixture. Seral IgG, colostral IgA and IgG titers from group B sows, and seral IgG and IgA levels in group B piglets were significantly higher than those of group A sows and piglets, respectively. After challenge with wild-type ETEC, diarrhea and mortality was not observed in group B piglets. However, diarrhea was observed in 66.7% of group A piglets, and 33.3% mortality was observed. These findings indicate that im immunization of sows with the mixture of the novel vaccine candidate can effectively protect their offspring from ETEC colibacillosis.
Abstract
Enterotoxigenic Escherichia coli (ETEC) strains producing each F4, F5, F6 and F41 fimbriae were lysed by GI24 peptide. The lysate cells were used as ETEC vaccine candidate. This study was carried out to examine whether intramuscular (im) immunization of pregnant sows with the novel vaccine candidate could effectively protect their neonatal piglets against ETEC colibacillosis. All pregnant sows were primed at 11 weeks and were boosted at 14 weeks of pregnancy. Group A sows were im inoculated with PBS. Group B sows were im immunized with 2×109 the mixture. Seral IgG, colostral IgA and IgG titers from group B sows, and seral IgG and IgA levels in group B piglets were significantly higher than those of group A sows and piglets, respectively. After challenge with wild-type ETEC, diarrhea and mortality was not observed in group B piglets. However, diarrhea was observed in 66.7% of group A piglets, and 33.3% mortality was observed. These findings indicate that im immunization of sows with the mixture of the novel vaccine candidate can effectively protect their offspring from ETEC colibacillosis.
참고문헌 (59)
- Arora A, "Refolded outer membrane protein A of Escherichia coli forms ion channels with two conductance states in planar lipid bilayers", J Biol Chem, 275, pp.1594~1600 (2000)
- Ascón M, "Oral immunization with a Salmonella Typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity", Infect Immun, 66, pp.5470~5476 (1998)
- Baek JH, "Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae)", Toxicon, 55, pp.711~718 (2010)
- Bertschinger HU, "Diseases of Swine", pp.431~468 (1999), Iowa State University Press
- Brumme S, "Impact of Salmonella Typhimurium DT104 virulence factors invC and sseD on the onset, clinical course, colonization patterns and immune response of porcine salmonellosis", Vet Microbiol, 124, pp.274~285 (2007)
- Carballar-Lejarazú R, "Recombinant scorpine : a multifunctional antimicrobial peptide with activity against different pathogens", Cell Mol Life Sci, 65, pp.3081~3092 (2008)
- Causey RC, "Immunisation of the equine uterus against Streptococcus equi subspecies zooepidemicus using an intranasal attenuated Salmonella vector", Vet J, 184, pp.156~161 (2010)
- Chen H, "Mucosal and systemic immune response to chimeric fimbriae expressed by Salmonella enterica serovar Typhimurium vaccine strains", Infect Immun, 68, pp.3129~3139 (2000)
- Chen X, "Prevalence of serogroups and virulence factors of Escherichia coli strains isolated from pigs with post weaning diarrhoea in eastern China", Vet Microbiol, 103, pp.13~20 (2004)
- Deprez P, "The influence of the administration of sow’s milk on the post-weaning excretion of hemolytic E. coli in the pig", Vet Res Commun, 10, pp.469~478 (1986)
- Dobrzyńska I, "Changes in electric charge and phospholipids composition in human colorectal cancer cells", Mol Cell Biochem, 276, pp.113~119 (2005)
- Ewaschuk JB, "Glutamine supplementation improves intestinal barrier function in a weaned piglet model of Escherichia coli infection", Br J Nutr, 106, pp.870~877 (2011)
- Haesebrouck F, "Efficacy of vaccines against bacterial diseases in swine: what can we expect?", Vet Microbiol, 100, pp.255~268 (2004)
- Haines LR, "Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18", PLoS Negl Trop Dis, 3, pp.e373~ (2009)
- Halas D, "Dietary supplementation with benzoic acid improves apparent ileal digestibility of total nitrogen and increases villous height and caecal microbial diversity in weaner pigs", Anim Feed Sci Technol, 160, pp.137~147 (2010)
- Harmsen MM, "Escherichia coli F4 fimbriae specific llsma single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhorea", Vet Microbiol, 111, pp.89~98 (2005)
- Holmgren J, "Mucosal immunity and vaccines", Nat Med, 11, pp.S45~S53 (2005)
- Hur J, "Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis", Vet Microbiol, 143, pp.270~276 (2010)
- Hur J, "Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model", J Vet Med Sci, 73, pp.1265~1273 (2011)
- Hur J, "Development of a novel live vaccine delivering enterotoxigenic Escherichia coli fimbrial antigens to prevent post-weaning diarrhea in piglets", Vet Immunol Immunopathol, 146, pp.283~288 (2012)
- Hur J, "Protection against neonatal Escherichia coli diarrhea by vaccination of sows with a novel multivalent vaccine candidate expressing E. coli adhesins associated with neonatal pig coli bacillosis", Res Vet Sci, 94, pp.198~204 (2013)
- Husseiny MI, "Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins", Vaccine, 27, pp.3780~3787 (2009)
- Jalava K, "Bacterial ghosts as vaccine candidates for veterinary applications", J Control Release, 85, pp.17~25 (2002)
- Jawale CV, "Characterization of a novel inactivated Salmonella enteritica serovar Enteritidis vaccine candidate generated using a modified cI857", λPR, Infect Immun, pp.2012, 80[DOI]
- Jawale CV, "Salmonella enterica serovar Enteritidis ghost carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses", Clin Vaccine Immunol, 21, pp.799~807 (2014)
- Kang HY, "Immune response to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine", Infect Immun, 70, pp.1739~1749 (2002)
- Katrien V, "Adjuvant effect of GantrezⓇ AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli", Vet Immunol Immunopathol, 139, pp.148~155 (2011)
- Kim YJ, "Isolation of Escherichia coli from piglets in South Korea with diarrhea and characteristics of the virulence genes", Can J Vet Res, 74, pp.59~64 (2010)
- Kiros TG, "Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PMMC, thymus, and lung lymphocytes of young pigs", Vet Immunol Immunopathol, 144, pp.448~454 (2011)
- Kramer DR, "Cytokine mediated effects in mucosal immunity", Immunol Cell Biol, 73, pp.389~396 (1995)
- Lambert GP, "Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects", J Anim Sci, 87, pp.E101~E108 (2009)
- Lessard M, "Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge", J Anim Sci, 87, pp.922~934 (2009)
- Li XQ, "Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: Intestinal microbiota and immune imbalances", PLoS ONE, 7, pp.e40666~ (2012)
- Liao CW, "Orally administrable enterotoxigenic Escherichia coli vaccine encapsulated by ethylcellulose powder dispersion", Appl Microbiol Biotechnol, 65, pp.295~300 (2004)
- Liu S, "Induction of specific immune responses in piglets by intramuscular immunization with fimbrial adhesin FaeG expressed in Lactoccus lactis", Res Vet Sci, 95, pp.130~136 (2013)
- Lv Y, "Antimicrobial properties and membrane-active mechanism of a potential α–helical antimicrobial derived from cathelicidin PMAP-36", PLoS One, 9, pp.e86364~ (2014)
- Marciani D, "Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity", Drug Discov Today, 8, pp.934~943 (2003)
- Matic JN, "Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA attenuated Salmonella enterica serovar Typhimurium", Infect Immun, 77, pp.1817~1826 (2009)
- Mayr UB, "Bacterial ghosts as an oral vaccine : a sing dose of Escherichia coli O157 : H7 bacterial ghosts protects mice against lethal challenge", Infect Immun, 73, pp.4810~4817 (2005)
- Mayr UB, "Bacterial ghosts as antigen delivery vehicles", Adv Drug Deliv Rev, 57, pp.1381~1391 (2005)
- Meeusen ENT, "Current status of veterinary vaccines", Clin Microbiol Rev, 20, pp.489~ (2007)
- Moreto M, "Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa", J Anim Sci, 87, pp.E92~E100 (2009)
- Moyle PM, "Mucosal immunisation: adjuvants and delivery systems", Curr Drug Deliv, 1, pp.385~396 (2004)
- Nagy B, "Enterotoxigenic Escherichia coli in farm animals", Vet Res, 30, pp.259~284 (1999)
- Nagy B, "Enterotoxigenic Escherichia coli in veterinary medicine", Int J Med Microbiol, 295, pp.443~454 (2005)
- Nataro JP, "Diarrheagenic Escherichia coli", Clin Microbiol Rev, 11, pp.142~201 (1998)
- Pace JL, "Inactivated whole-cell bacterial vaccines : current status and novel strategies", Vaccine, 16, pp.1563~1574 (1998)
- Pascual DW, "Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages", Infect Immun, 70, pp.4273~4281 (2002)
- Pathangey L, "Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines", Vaccine, 27, pp.2707~2711 (2009)
- Puiprom O, "Identification of colonization factors of enterotoxigenic Escherichia coli with PCR-based technique", Epidemiol Infect, 138, pp.519~524 (2010)
- Remer KA, "Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88", Int J Med Microbiol, 299, pp.467~478 (2009)
- Rutter JM, "Protection against enteric disease caused by Escherichia coli-a model for vaccination with a virulence determinant?", Nature, 242, pp.531~532 (1973)
- Singh SP, "The-C-terminal domain of Salmonella enterica serovar Typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surface", Infect Immun, 71, pp.3937~3946 (2003)
- Snoeck V, "Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections", Vet Immunol Immunopathol, 96, pp.219~227 (2003)
- Tabrizi CA, "Bacterial ghosts – biological particles as delivery systems for antigens, nucleic acids and drugs", Curr Opin Biotechnol, 15, pp.530~537 (2004)
- Teixeira V, "Role of lipids in the interaction of antimicrobial peptides with membranes", Prog Lipid Res, 51, pp.149~177 (2012)
- Vila-Farres X, "In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii", Clin Microbiol Infect, 18, pp.383~387 (2012)
- Vu-Khac H, "Serotypes, virulence genes, intimin types and PFGE profiles of Escherichia coli isolated from piglets with diarrhea in Slovakia", Vet J, 174, pp.176~187 (2007)
- Yang Y, "Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella Typhimurium elicits a protective immune response against Trichinella spiralis larval challenge", Vaccine, 28, pp.2735~2742 (2010)
